UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington D.C. 20549
 
Form 6-K
 
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13A-16 OR 15D-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934

For the month of August 2024
Commission File Number: 001-41641

SHL TELEMEDICINE LTD.
 (Translation of registrant’s name into English)

90 Yigal Alon Street
Tel Aviv 67891, Israel
(Address of principal executive offices)

Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.

Form 20-F ☒             Form 40-F ☐

EXPLANATORY NOTE
 
On August 26, 2024, SHL Telemedicine Ltd. (the “Company”) issued a press release, a copy of which is furnished herewith as Exhibit 99.1. This Form 6-K is incorporated by reference into the Company's Registration Statement on Form S-8 filed with the Securities and Exchange Commission on June 9, 2023 (Registration No. 333-272546).

Exhibit Description

99.1

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

  SHL Telemedicine Ltd.  

     

By:
/s/ Amir Hai  

  Amir Hai  
    Chief Financial Officer  

August 26, 2024

Exhibit 99.1

 
Press release

Ad hoc announcement pursuant to Art. 53 LR

SHL Telemedicine’s Chairman announced he is stepping down
 
Following the August 2, 2024 announcement, Mr. Alroy informed the Company that he is also departing from the Company’s Board of Directors.
 
Tel Aviv / Zurich / New York, August 26, 2024 - SHL Telemedicine Ltd. (NASDAQ: SHLT, SIX: SHLTN;) ("SHL" or the "Company"), a leading provider and developer of advanced personal telemedicine solutions, has announced today that Mr. Yariv Alroy, Chairman of SHL, has informed the Company that he will be stepping down as Chairman and resign from the Board of Directors effective as of today.

The process of the board search committee to identify an appropriate person to be appointed as Chairman is progressing.
 
About SHL Telemedicine
 
SHL Telemedicine is engaged in developing and marketing personal telemedicine systems and the provision of medical call center services, with a focus on cardiovascular and related diseases, to end users and to the healthcare community. SHL Telemedicine offers its services and personal telemedicine devices to subscribers utilizing telephonic and Internet communication technology. SHL is listed on the SIX Swiss Exchange (SHLTN, ISIN: IL0010855885, Security No.: 1128957) and on the Nasdaq Stock Exchange (SHLT, ISIN: US78423T2006, CUSIP: 78423T200).
 
For more information, please visit our website at www.shl-telemedicine.com.
 
Contacts
 
Fabienne Farner, IRF, Phone : +41 43 244 81 42, farner@irf-reputation.ch
 
Forward-Looking Statements
 
Some of the information contained in this press release contains forward-looking statements. Readers are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, and that actual results may differ materially from those in the forward-looking statements as a result of various factors. SHL Telemedicine undertakes no obligation to publicly update or revise any forward-looking statements.
 

SHL Telemedicine (NASDAQ:SHLT)
Historical Stock Chart
From Oct 2024 to Nov 2024 Click Here for more SHL Telemedicine Charts.
SHL Telemedicine (NASDAQ:SHLT)
Historical Stock Chart
From Nov 2023 to Nov 2024 Click Here for more SHL Telemedicine Charts.